Skip to main content

Table 1 PSMA vascular expression in primary and metastatic tumors

From: Peritumoral/vascular expression of PSMA as a diagnostic marker in hepatic lesions

Ā 

PSMA vascular expression

Case (n)

Positive (n,%)

Negative (n,%)

Primary

42

28(66.7%)

14(33.3%)

ā€ƒHCC

22

15(68.2%)

7(31.8%)

ā€ƒCholangiocarcinoma

15

13(86.7%)

2(13.3%)

ā€ƒHepatic adenoma

5

0(0.0%)

5(100.0%)

Metastatic

30

2(6.7%)

28(93.3%)

ā€ƒPancreatic ductal

18

0(0.0%)

18(100.0%)

ā€ƒOther sites*

12

2(16.6%)**

10(83.3%)

  1. *Other sites includes liver metastatic tumor original from colon (3), lung (1) and prostate (8)
  2. **In total 5 cases of metastatic prostate cancer showed positivity in PSMA, 2 of which had both tumor cell and peritumoral/vascular pattern, and the rest 3 cases were tumor cell positive only (counted in negative column)